UNLIMITED TURBO SHORT - MERCK & CO. Share Price

Certificat

9OVJB

NLBNPNL27PP9

Market Closed - Euronext Paris 10:00:02 03/07/2024 pm IST
1.396 EUR +11.68% Intraday chart for UNLIMITED TURBO SHORT - MERCK & CO.
Current month+22.24%
1 month+11.59%
Date Price Change
03/24/03 1.396 +11.68%
02/24/02 1.25 +8.23%
01/24/01 1.155 +1.14%
28/24/28 1.142 +1.42%
27/24/27 1.126 +61.09%

Real-time Euronext Paris

Last update July 03, 2024 at 10:00 pm IST

More quotes

Static data

Product typeCertificat Turbo
Buy / SellPUT
Underlying MERCK & CO., INC.
IssuerLogo Issuer BNP Paribas BNP Paribas
9OVJB
ISINNLBNPNL27PP9
Date issued 09/01/2023
Strike 139.7 $
Maturity Unlimited
Parity 10 : 1
Emission price 2.7
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 4.1
Lowest since issue 0.596

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
125.8 USD
Average target price
142.7 USD
Spread / Average Target
+13.37%
Consensus
  1. Stock Market
  2. Certificates
  3. 9OVJB Certificat